Vitara Biomedical, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2019

Location

Philadelphia PA US

Primary Industry

Medical Devices & Equipment

About

Based in Pennsylvania, US, and founded in 2019, Vitara Biomedical, Inc. develops therapeutic medical devices for premature infants and provides physiological procedures for neonatal care for newborns to help lower mortality and comorbidities. In November 2024, Vitara Biomedical, Inc. raised USD 50 million in series B funding led by new investor Sands Capital Ventures, with participation from other new investors GV, First Spark Ventures, Khosla Ventures, and Flerie Invest. The company is developing a therapeutic platform for premature infants that is inspired by natural physiological processes and has the potential to transform neonatal care. The organization plans to use the July 2022 funding to advance its artificial womb technology for premature babies. The organization plans to use the November 2024 funding to advance its efforts toward a first-in-human clinical study of its technology.

Current Investors

Khosla Ventures, GV, Sands Capital Ventures

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Therapeutic Devices

Website

www.vitara.com

Verticals

HealthTech, Manufacturing

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.